tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Baum, 21 are a HOLD (33.33%), 40 are a BUY (63.49%), 2 are a SELL (3.17%).
Analyst Andrew Baum, currently employed at CITI, carries an average stock price target met ratio of 62.23% that have a potential upside of 19.58% achieved within 379 days.
Andrew Baum’s has documented 130 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 13-Sep-2024.
Analyst best performing recommendations are on ALVO (ALVOTECH).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/26/2023. The price target of $525 was fulfilled within 19 days with a profit of $74.77 (16.61%) receiving and performance score of 8.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$209
$15.24 (7.87%)
$190
1 months 12 days ago
40/41 (97.56%)
$11.45 (5.80%)
477
Buy
$218
$24.24 (12.51%)
$196
1 months 23 days ago
12/13 (92.31%)
$27.82 (14.63%)
488
Buy
$200
$6.24 (3.22%)
$200
2 months ago
0/5 (0%)
$15.64 (8.48%)
Buy
$205
$11.24 (5.80%)
$180
2 months 9 days ago
4/6 (66.67%)
$19.84 (10.72%)
498
Buy
$210
$16.24 (8.38%)
$195
2 months 9 days ago
10/11 (90.91%)
$24.84 (13.42%)
426
Which stock is Andrew Baum is most bullish on?
What Year was the first public recommendation made by Andrew Baum?
